| 1 | [SID26661382] | Active | Potency | 0.7079 | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2517, Type: confirmatory] | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 0.7079 [uM] | | BioAssay | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) | | AID | 2517 | | BioAssay type | confirmatory | | Target | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] | | PubMed | | | Data Table |  |
|
| 2 | [SID26661382] | Active | AC50 | 0.798 | Fluorescent Polarization Homogeneous Dose Retest to Confirm Inhibitors of Mex-5 Binding to TCR-2 [AID449745, Type: confirmatory] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | AC50 | 0.798 [uM] | | BioAssay | Fluorescent Polarization Homogeneous Dose Retest to Confirm Inhibitors of Mex-5 Binding to TCR-2 | | AID | 449745 | | BioAssay type | confirmatory | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 3 | [SID26661382] | Active | AC50 | 0.798 | Fluorescent Polarization Homogeneous Dose Retest to Confirm Inhibitors of Mex-5 Binding to TCR-2 [AID449745, Type: confirmatory] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | AC50 | 0.798 [uM] | | BioAssay | Fluorescent Polarization Homogeneous Dose Retest to Confirm Inhibitors of Mex-5 Binding to TCR-2 | | AID | 449745 | | BioAssay type | confirmatory | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 4 | [SID26661382] | Active | Potency | 1.4125 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 1.4125 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 5 | [SID26661382] | Active | Potency | 1.4125 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 1.4125 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 6 | [SID26661382] | Active | Potency | 1.5849 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 7 | [SID26661382] | Active | Potency | 1.5849 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 8 | [SID26661382] | Active | Potency | 2.2387 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 9 | [SID26661382] | Active | IC50 | 2.28005 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | IC50 | 2.28005 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 10 | [SID26661382] | Active | IC50 | 2.28005 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | IC50 | 2.28005 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 11 | [SID26661382] | Active | IC50 | 2.28005 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | IC50 | 2.28005 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 12 | [SID26661382] | Active | AC50 | 2.312 | POS-1 FP counterscreen Measured in Biochemical System Using Plate Reader - 2024-02_Inhibitor_Dose_CherryPick_Activity_Set2 [AID493130, Type: confirmatory] | POsterior Segregation family member (pos-1) [Caenorhabditis elegans] [gi:17562800] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | AC50 | 2.312 [uM] | | BioAssay | POS-1 FP counterscreen Measured in Biochemical System Using Plate Reader - 2024-02_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 493130 | | BioAssay type | confirmatory | | Target | POsterior Segregation family member (pos-1) [Caenorhabditis elegans] [gi:17562800] | | PubMed | | | Data Table |  |
|
| 13 | [SID26661382] | Active | Potency | 2.8184 | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay [AID504375, Type: confirmatory] | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay | | AID | 504375 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] | | PubMed | | | Data Table |  |
|
| 14 | [SID26661382] | Active | Potency | 2.8184 | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay [AID504375, Type: confirmatory] | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay | | AID | 504375 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] | | PubMed | | | Data Table |  |
|
| 15 | [SID26661382] | Active | Potency | 3.9811 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 16 | [SID26661382] | Active | Potency | 3.9811 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 17 | [SID26661382] | Active | Potency | 4.1095 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 4.1095 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID26661382] | Active | Potency | 6.3096 | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2549 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 19 | [SID26661382] | Active | Potency | 6.3096 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 20 | [SID26661382] | Active | Potency | 6.3096 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 21 | [SID26661382] | Active | Potency | 7.9245 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 7.9245 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 22 | [SID26661382] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 23 | [SID26661382] | Active | Potency | 8.9125 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 24 | [SID26661382] | Active | Potency | 10.691 | Tb PFK orthogonal confirmatory assay using ATP depletion (Kinase-Glo Plus) as an alternative measure of Tb PFK activity: Hit Validation [AID504636, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 10.691 [uM] | | BioAssay | Tb PFK orthogonal confirmatory assay using ATP depletion (Kinase-Glo Plus) as an alternative measure of Tb PFK activity: Hit Validation | | AID | 504636 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 25 | [SID26661382] | Active | Potency | 11.2202 | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 26 | [SID26661382] | Active | Potency | 16.9441 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 16.9441 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 27 | [SID26661382] | Active | Potency | 19.0115 | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase [AID485367, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 19.0115 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase | | AID | 485367 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 28 | [SID26661382] | Active | Potency | 22.3872 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 29 | [SID26661382] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 30 | [SID26661382] | Active | Potency | 26.8545 | Inhibitors of T. brucei phosphofructokinase: Hit Validation [AID504637, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 26.8545 [uM] | | BioAssay | Inhibitors of T. brucei phosphofructokinase: Hit Validation | | AID | 504637 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 31 | [SID26661382] | Active | Potency | 35.4813 | Counterscreen for RECQ1 Inhibitors: ADP Fluorescence Polarization Displacement Assay [AID2711, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | Counterscreen for RECQ1 Inhibitors: ADP Fluorescence Polarization Displacement Assay | | AID | 2711 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID26661382] | Active | Potency | 35.4813 | Counterscreen for BLMA Inhibitors: ADP Fluorescence Polarization Displacement Assay [AID2712, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | Counterscreen for BLMA Inhibitors: ADP Fluorescence Polarization Displacement Assay | | AID | 2712 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID26661382] | Active | Potency | 50.1187 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 34 | [SID26661382] | Active | Potency | 79.4328 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 35 | [SID26661382] | Active | Potency | 79.4328 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 36 | [SID26661382] | Active | Potency | 79.4328 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 37 | [SID26661382] | Active | Potency | 79.4328 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 38 | [SID26661382] | Active | IC50 | | uHTS HTRF assay for identification of inhibitors of SUMOylation [AID2006, Type: confirmatory] | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS HTRF assay for identification of inhibitors of SUMOylation | | AID | 2006 | | BioAssay type | confirmatory | | Target | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] | | PubMed | | | Data Table |  |
|
| 39 | [SID26661382] | Active | | | uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation [AID782, Type: screening] | eukaryotic translation initiation factor 4E [Mus musculus] [gi:83627717] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | BioAssay | uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation | | AID | 782 | | BioAssay type | screening | | Target | eukaryotic translation initiation factor 4E [Mus musculus] [gi:83627717] | | PubMed | | | Data Table |  |
|
| 40 | [SID26661382] | Active | | | uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation [AID782, Type: screening] | eukaryotic translation initiation factor 4E [Mus musculus] [gi:83627717] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | BioAssay | uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation | | AID | 782 | | BioAssay type | screening | | Target | eukaryotic translation initiation factor 4E [Mus musculus] [gi:83627717] | | PubMed | | | Data Table |  |
|
| 41 | [SID26661382] | Active | IC50 | | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) [AID2012, Type: confirmatory] | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) | | AID | 2012 | | BioAssay type | confirmatory | | Target | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] | | PubMed | | | Data Table |  |
|
| 42 | [SID26661382] | Active | | | Confirmation biochemical high throughput screening assay for inhibitors of Retinoblastoma binding protein 9 (RBBP9) [AID1537, Type: screening] | putative hydrolase RBBP9 [Homo sapiens] [gi:24119166] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | BioAssay | Confirmation biochemical high throughput screening assay for inhibitors of Retinoblastoma binding protein 9 (RBBP9) | | AID | 1537 | | BioAssay type | screening | | Target | putative hydrolase RBBP9 [Homo sapiens] [gi:24119166] | | PubMed | | | Data Table |  |
|
| 43 | [SID26661382] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9) [AID1515, Type: screening] | putative hydrolase RBBP9 [Homo sapiens] [gi:24119166] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9) | | AID | 1515 | | BioAssay type | screening | | Target | putative hydrolase RBBP9 [Homo sapiens] [gi:24119166] | | PubMed | | | Data Table |  |
|
| 44 | [SID26661382] | Active | | | Kallikrein 5 1536 HTS [AID873, Type: screening] | kallikrein-related peptidase 5 preproprotein [Homo sapiens] [gi:6912644] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | BioAssay | Kallikrein 5 1536 HTS | | AID | 873 | | BioAssay type | screening | | Target | kallikrein-related peptidase 5 preproprotein [Homo sapiens] [gi:6912644] | | PubMed | | | Data Table |  |
|
| 45 | [SID26661382] | Active | | | Kallikrein 5 1536 HTS [AID873, Type: screening] | kallikrein-related peptidase 5 preproprotein [Homo sapiens] [gi:6912644] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | BioAssay | Kallikrein 5 1536 HTS | | AID | 873 | | BioAssay type | screening | | Target | kallikrein-related peptidase 5 preproprotein [Homo sapiens] [gi:6912644] | | PubMed | | | Data Table |  |
|
| 46 | [SID26661382] | Active | | | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen [AID1832, Type: screening] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | BioAssay | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen | | AID | 1832 | | BioAssay type | screening | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 47 | [SID26661382] | Active | | | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen [AID1832, Type: screening] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | BioAssay | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen | | AID | 1832 | | BioAssay type | screening | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 48 | [SID26661382] | Active | | | QFRET-based biochemical high throughput confirmation assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). [AID2170, Type: screening] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | BioAssay | QFRET-based biochemical high throughput confirmation assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). | | AID | 2170 | | BioAssay type | screening | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 49 | [SID26661382] | Active | | | QFRET-based biochemical high throughput confirmation assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). [AID2170, Type: screening] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | BioAssay | QFRET-based biochemical high throughput confirmation assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). | | AID | 2170 | | BioAssay type | screening | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 50 | [SID26661382] | Active | | | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). [AID1822, Type: screening] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26661382 | | CID | 54688357 | | Outcome | Active | | BioAssay | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). | | AID | 1822 | | BioAssay type | screening | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|